Catyalyst Pharma (CPRX) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $15.12 --0%
EPS Growth %: -46.3%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
UXIN, TOWN, NRIM, More
EPS Growth %: -46.3%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
UXIN, TOWN, NRIM, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q2 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brunswick (BC) Reports In-Line Q1 EPS, provides guidance
- Applied Industrial Technologies (AIT) Tops Q3 EPS by 8c; Updates outlook
- Dover Corp. (DOV) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY24 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
